Candidate exome capture identifies mutation of <em>SDCCAG8</em> as the cause of a retinal-renal ciliopathy by Otto, Edgar A et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Candidate exome capture identifies mutation of SDCCAG8 as the
cause of a retinal-renal ciliopathy
Citation for published version:
Otto, EA, Hurd, TW, Airik, R, Chaki, M, Zhou, W, Stoetzel, C, Patil, SB, Levy, S, Ghosh, AK, Murga-
Zamalloa, CA, van Reeuwijk, J, Letteboer, SJF, Sang, L, Giles, RH, Liu, Q, Coene, KLM, Estrada-Cuzcano,
A, Collin, RWJ, McLaughlin, HM, Held, S, Kasanuki, JM, Ramaswami, G, Conte, J, Lopez, I, Washburn, J,
Macdonald, J, Hu, J, Yamashita, Y, Maher, ER, Guay-Woodford, LM, Neumann, HPH, Obermüller, N,
Koenekoop, RK, Bergmann, C, Bei, X, Lewis, RA, Katsanis, N, Lopes, V, Williams, DS, Lyons, RH, Dang,
CV, Brito, DA, Dias, MB, Zhang, X, Cavalcoli, JD, Nürnberg, G, Nürnberg, P, Pierce, EA, Jackson, PK,
Antignac, C, Saunier, S, Roepman, R, Dollfus, H, Khanna, H & Hildebrandt, F 2010, 'Candidate exome
capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy' Nature Genetics, vol 42,
no. 10, pp. 840-850. DOI: 10.1038/ng.662
Digital Object Identifier (DOI):
10.1038/ng.662
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Nature Genetics
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 28. Apr. 2017
Candidate exome capture identifies mutation of SDCCAG8 as
the cause of a retinal-renal ciliopathy
Edgar A. Otto1,36, Toby W. Hurd1,36, Rannar Airik1, Moumita Chaki1, Weibin Zhou1, Corinne
Stoetzel2, Suresh B. Patil3, Shawn Levy4, Amiya K. Ghosh1, Carlos A. Murga-Zamalloa3,
Jeroen van Reeuwijk5, Stef J.F. Letteboer5, Liyun Sang6, Rachel H. Giles7, Qin Liu8, Karlien
L. M. Coene5, Alejandro Estrada-Cuzcano5, Rob W. J. Collin5, Heather M. McLaughlin1,
Susanne Held1, Jennifer M. Kasanuki1, Gokul Ramaswami1, Jinny Conte9, Irma Lopez9,
Joseph Washburn10, James MacDonald1, Jinghua Hu11, Yukiko Yamashita12, Eamonn R.
Maher13, Lisa Guay-Woodford14, Hartmut P.H. Neumann15, Nicholas Obermüller16, Robert
K. Koenekoop9, Carsten Bergmann17, Xiaoshu Bei18,19,20, Richard A. Lewis21, Nicholas
Katsanis18,19,20, Vanda Lopes22, David S. Williams22, Robert H. Lyons23, Chi V. Dang24,
Daniela A. Brito25, Mónica Bettencourt Dias25, Xinmin Zhang26, Gudrun Nürnberg27,28,29,
Peter Nürnberg27,28,29, Eric Pierce8, Peter Jackson6, Corinne Antignac30,31, Sophie
Saunier30, Ronald Roepman5,32, Helene Dollfus2,33, Hemant Khanna3, and Friedhelm
Hildebrandt1,34,35
1Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor,
Michigan 48109, USA 2Laboratoire de Génétique Médicale EA3949, Equipe AVENIR-Inserm,
Faculté de Médecine, Université de Strasbourg, 11 rue Humann, 67000 Strasbourg, France
3Department of Ophthalmology and Visual Sciences, Ann Arbor, Michigan 48109, USA
4HudsonAlpha Institute for Biotechnology, 601 Genome Way, Huntsville, Alabama 35806, USA
5Department of Human Genetics and Nijmegen Centre for Molecular Life Sciences, Nijmegen,
The Netherlands 6Department of Cell Regulation, Genentech Inc., South San Francisco,
California 94080, USA 7Department of Medical Oncology, University Medical Center, Utrecht, The
Netherlands 8F.M. Kirby Center for Molecular Ophthalmology, University of Pennsylvania School
of Medicine, Philadelphia, Pennsylvania, USA 9McGill Ocular Genetics Laboratory, Montreal
Children’s Hospital, McGill University Health Centre, Montreal, H3H 1P3, Canada 10Cancer
Center, University of Michigan, Ann Arbor, Michigan 48109, USA 11Department of Biochemistry
and Molecular Biology, Mayo Clinic, Rochester, Minnesota 55905, USA 12Department of Cell and
Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research,
subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
Correspondence should be addressed to: Friedhelm Hildebrandt, M.D. Howard Hughes Medical Institute University of Michigan
Health System 8220C MSRB III, 1150 West Medical Center Drive Ann Arbor, MI 48109-5646, USA Phone: +1 734 615-7285
(office), +1 734 615-7895, -7896 (laboratories); Fax: +1 734-615-1386, -7770 fhilde@umich.edu..
Author Contributions E.A.O, H.M, S.H., J.M.K and G.R. generated total genome linkage, exon capture, and gene identification data.
T.W.H gereated antibody characterization, immunoprecipitation, and cell cycle expression data. R.A., M.C., H.K., A.K.G., S.B.P.,
C.A.M-Z, J.H., Y.Y and C.V.D. performed immunofluorescence and subcellular localization studies by confocal microscopy. W.Z.
performed zebrafish experiments. J.R, S.J.F.L, R.R. contributed the OFD1 work. L.S., R.H.G., P.J. generated spheroid assay and
protein expression data. Q.L and E.P. performed retina electroporation studies. C.A., S.S., E.R.M., L.G-W., H.P.H.N, N.O. and C.B.
recruited patients and gathered detailed clinical information for the study. N.K., X.B., R.A.L., R.K.K, J.C., I.L., K.L.M.C, A.E-C,
R.W.J.C performed mutation analysis. D.A.B., M.B.D and V.L., D.S.W. performed high-resolution confocal microscopy and EM
studies, respectively. S.L., R.H.L. and X.Z. performed large-scale sequencing or exon capture. G.N., P.N., J. W., J. M. did linkage
calculations. H.D. and C.S. independently mapped and identified SDCCAG8 in FII.22 and FI.2. F.H. conceived of and directed the
entire project and wrote the paper with contributions from R.R. and H.D.
36These authors contributed equally to this work.
Competing interests statement The authors declare that they have no competing financial interests.
Accession numbers. SDCCAG8 full-length isoform-a is GenBank accession number NM_006642.2 and human isoform-e is
accession number BC032454.
NIH Public Access
Author Manuscript
Nat Genet. Author manuscript; available in PMC 2011 April 1.
Published in final edited form as:
Nat Genet. 2010 October ; 42(10): 840–850. doi:10.1038/ng.662.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Developmental Biology, University of Michigan, MI 48109, USA 13Department of Medical and
Molecular Genetics, School of Clinical and Experimental Medicine and Centre for Rare Diseases
and Personalised Medicine, University of Birmingham, Institute of Biomedical Research,
Edgbaston, Birmingham B15 2TT, UK 14UAB Center for Clinical and Translational Science,
University of Alabama at Birmingham, Birmingham, Alabama 35294, USA 15Department of
Nephrology and General Medicine, University Medical Center, Albert-Ludwigs-University,
Freiburg i.Br., Germany 16Department of Nephrology, III. Medical Clinic, University Hospital,
Frankfurt, Germany 17Universitaetsklinikum Aachen, Aachen, Germany 18Center for Human
Disease Modeling, Duke University Medical Center, Durham, North Carolina 27710, USA
19Department of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710,
USA 20Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710,
USA 21Department of Ophthalmology, Baylor College of Medicine, Houston, Texas 77030, USA
22Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles, California 90095, USA
23Department of Biological Chemistry, and DNA Sequencing Core, University of Michigan, Ann
Arbor, Michigan 48109, USA 24Johns Hopkins University School of Medicine, Baltimore, Maryland
21201, USA 25Instituto Gulbenkian de Ciência, Rua da Quinta Grande 6, 6P-2780-156 Oeiras,
Portugal 26Roche NimbleGen, Inc., Madison, Wisconsin, USA 27Cologne Center for Genomics,
University of Cologne, Cologne, Germany 28Center for Molecular Medicine Cologne, University of
Cologne, Cologne, Germany 29Cologne Excellence Cluster on Cellular Responses in Aging-
Associated Diseases, University of Cologne, Cologne, Germany 30Department of Genetics,
Hôpital Necker-Enfants Malades, Assistance Publique–Hôpitaux de Paris, Paris, France
31INSERM U-983, Hôpital Necker-Enfants Malades, Université Paris Descartes, Paris, France
32Institute for Genetic and Metabolic Disease, Radboud University Nijmegen Medical Centre,
Nijmegen, The Netherlands 33Centre de Référence pour les Affections Rares en Génétique
Ophtalmologique (CARGO) et Service de Génétique Médicale, Hôpitaux Universitaires de
Strasbourg, Strasbourg, France 34Department of Human Genetics, University of Michigan, Ann
Arbor, Michigan 48109, USA 35Howard Hughes Medical Institute, Chevy Chase, Maryland 20815,
USA
Abstract
Nephronophthisis-related ciliopathies (NPHP-RC) are recessive disorders featuring dysplasia or
degeneration preferentially in kidney, retina, and cerebellum. Here we combine homozygosity
mapping with candidate gene analysis by performing “ciliopathy candidate exome capture”
followed by massively-parallel sequencing. We detect 12 different truncating mutations of
SDCCAG8 in 10 NPHP-RC families. We demonstrate that SDCCAG8 is localized at both
centrioles and directly interacts with NPHP-RC-associated OFD1. Depletion of sdccag8 causes
kidney cysts and a body axis defect in zebrafish and induces cell polarity defects in 3D renal cell
cultures. This work identifies SDCCAG8 loss of function as a novel cause of a retinal-renal
ciliopathy and validates exome capture analysis for broadly heterogeneous single-gene disorders.
INTRODUCTION
Nephronophthisis (NPHP) is a recessive cystic kidney disease that represents the most
frequent genetic cause of end-stage kidney disease in the first three decades of life. NPHP-
related ciliopathies (NPHP-RC) are single-gene recessive disorders, which cause retinal-
renal ciliopathies that affect kidney, retina, brain and liver by prenatal-onset dysplasia or by
childhood-onset tissue degeneration. So far 9 different NPHP genes have been identified as
causing NPHP-RC (NPHP1-NPHP9)1-11. The finding that proteins mutated in cystic kidney
diseases are located at the primary cilium-centrosome complex provided a unifying disease
mechanism for NPHP-RC characterizing them as ciliopathies. Many of the NPHP-RC gene
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products interact at the cilium-centrosome complex throughout the cell cycle. We recently
demonstrated in a large cohort of 1,167 families with NPHP-RC that in more than 70% of
cases the causative gene is unknown12. Furthermore, in families with severe forms of
NPHP-RC we did not detect a mutation in any of the nine known NPHP-RC causing genes
in 90 of 120 families (75%) (Otto et al., unpublished). Upon homozygosity mapping, 50 of
these families exhibited putative homozygous disease loci, of which more than 30 showed
no positional overlap, strongly indicating that many additional recessive NPHP-RC genes
must exist.
RESULTS
Homozygosity mapping focuses exome capture
The finding that recently discovered NPHP-RC genes caused the disorder only in a small
number of cases (<1%)9 necessitated the ability to map and identify disease genes in single
families. We therefore developed a strategy that combines homozygosity mapping in single
families13 with exon capture and consecutive massively parallel (MP) sequencing.14 Using
the NimbleGen™ 385k platform we designed a ciliopathy candidate exon capture (CEC)
array”, which contains oligonucleotides that interrogate ~13,000 exons from the “UCSC
Gene” annotation (genome.ucsc.edu) of 828 NPHP-RC candidate genes. Candidates were
derived from ciliopathy animal models, from the photoreceptor sensory cilia proteome15
and other candidate sources16 (Supplementary Table 1 Online).
Because exon capture with consecutive MP sequencing bears the problem of yielding too
many variants from normal reference sequence (VRS) for making a safe call regarding the
disease-causing mutation14, we devised a strategy of a priori reduction of VRS
(Supplementary Table 1). These a priori restriction criteria consisted of, i) capturing only
~13,000 ciliopathy candidate exons instead of all ~180,000 CCDS exons (~15-fold
reduction) (Supplementary Table 1), ii) evaluation of coding SNPs, splice variants and
indels only (as other variants will be difficult to interpret), iii) absence of VRSs from a
database of innocuous single nucleotide polymorphisms (dbSNP130) (2.3-fold reduction),
iv) evaluation only within the mapped homozygous candidate region of an individual or
family (~20-fold reduction), and v) preferential evaluation of truncating mutations (~4-fold
reduction). This approach allowed a mean reduction of VRS by ~2,760-fold and led to the
identification of the disease-causing gene in 3 out of 5 attempts (Supplementary Table 1).
Homozygous mutations were discovered in the known NPHP-RC genes AHI1 (family
A2045) and INVS (family A128) (Supplementary Table 1 Online). More importantly, a
homozygous mutation was discovered in SDCCAG8 as a novel cause of NPHP-RC.
Null-mutations of SDCCAG8 cause retinal-renal degeneration
Specifically, in consanguineous family SS23/A1365 two siblings had Senior-Loken
syndrome (SLSN), the association of nephronophthisis with retinal degeneration.
Homozygosity mapping using the Affymetrix 250k StyI SNP platform yielded four
segments of homozygosity (Fig. 1a).13 Because none of the 4 homozygous segments (red
circles in Fig. 1a) coincided with any of the 9 known gene loci for NPHP-RC (dashed lines
in Fig. 1a) we hypothesized that SLSN in SS23/A1365 must be caused by recessive
mutations of a novel NPHP-RC causing gene. Exon capture and MP sequencing (Fig. 1b)
led to the identification of a homozygous truncation mutation (p.E474fsX493) in SDCCAG8
(Fig. 1c-f, Table 1).
When investigating 11 families with NPHP-RC, in whom we had demonstrated
homozygosity at the SDCCAG8 locus13 we detected four additional homozygous mutations
(Fig. 1f). These were, (i) a deletion of exons 5-7 in F159, (ii) an obligatory splice site
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mutation (c.1068+1G>A) in A2290, (iii) a homozygous 1-bp insertion (resulting in
p.E447fsX463) in SS-F336, and (iv) a homozygous nonsense mutation (p.L599X) in F1054.
Direct exon sequencing of 118 families with SLSN yielded a 4-bp deletion resulting in a
reading frame shift of the deduced amino acid sequence (p.C649fsX658) in F195 (Fig. 1f
and Table 1). No mutations were detected by direct exon sequencing in 54 families with
Joubert syndrome who had renal involvement with NPHP. All mutations were absent from
>270 healthy control individuals and from healthy controls of the “1,000 genomes project”
(http://www.1000genomes.org/page.php) (Table 1).
Furthermore, an independent homozygosity mapping study (using the Affymetrix 6.0 SNP)
was carried out on 22 consanguineous families diagnosed as having Bardet-Biedl syndrome
and for which no mutation was detected on genomic sequencing of 12 known BBS genes. A
unique segment of homozygosity was identified for a large family (FI.2) on chromosome 1
(240 - 242.38 Mb) encompassing 5 genes (PLD5, CEP170, SDCCAG8, AKT3, ZNF238),
for which sequencing of all coding exons was normal. Subsequently, RT-PCR with
overlapping primer sets for the five genes was performed on RNA from fibroblast cell lines
derived from the four affected family members. Abnormal fragments were obtained when
amplifying exons 7 and 8 of SDCCAG8 (Supplementary Fig. 1 Online A,B). Sequencing of
the products revealed various complex aberrant intron 7 insertions with a homozygous deep
intronic mutation, c.740+356c>t, predicted to cause loss of an Exonic Splice Enhancer
(ESE) site with the result of aberrant splicing introducing an in-frame stop codon
(Supplementary Fig. 1 Online C-E).17 This leads to almost complete absence of the full-
length SDCCAG8 product as confirmed by RT-PCR and immunoblotting (Supplementary
Fig. 1 Online F-H). The finding that some residual full-length splice product and protein
product remains (Supplementary Fig. 1 Online A,B and F-H) may explain the relatively late
onset of renal failure and retinal degeneration observed in this kindred (Table 1).
Quantitative PCR analysis performed with primers bordering exons 8 and 9 amplified a
significantly lower level of RNA compared to the control and Western blot confirmed trace
amounts of protein (data not shown). The mutation was absent from >270 healthy control
individuals and segregated with the disease in the family. In the same study, another
consanguineous family (FII.22) with two siblings diagnosed with BBS (on the basis of
obesity and mild mental retardation) showed overlapping homozygosity for the same
chromosome 1 region. Exon sequencing of SDCCAG8 revealed a homozygous nonsense
mutation (p.K227X). Because of these data, we initiated an unbiased (with regard to
mutations at other loci) sequencing of SDCCAG8 in 96 unrelated BBS patients and found
two families in which compound heterozygous loss of function mutations appeared
sufficient to cause the disorder. Family NK-F1063 carried two deletions, causing frame
shifts (p.T482fsX493 and p.D543fsX566), whereas in AR37, we found a nonsense allele and
a frame shifting deletion (p.Y232X and p.R247fsX250) (Table 1). Both families had some
of the six primary features of BBS (retinal degeneration, postaxial polydactyly, truncal
obesity, learning disabilities, hypogonadism and renal anomalies).18 However, none of the
patients had polydactyly (Table 1). We also detected two unique heterozygous alleles in two
additional families, a p.E520G change in Northern European family AR605, and an
p.E531K in middle-Eastern family KK11 (data not shown). No SDCCAG8 mutation was
identified in 40 other BBS families, who did not carry a known BBS gene mutation.
Likewise, no mutations were detected upon direct exon sequencing of 90 unrelated famlies
with isolated juvenile-onset retinitis pigmentosa. All individuals from 10 families with 12
different homozygous or compound heterozygous truncating mutations in SDCCAG8 had
nephronophthisis and retinal degeneration (Senior-Loken syndrome) (Table 1). Some had
mild mental retardation, and two had signs of Bardet-Biedl syndrome (obesity and
hypogenitalism).19 We thus identified recessive mutations of SDCCAG8 as a new cause of
SLSN with some additional BBS-related features. Interestingly, all 10 families had two
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truncating mutations and exhibited a degenerative phenotype of kidney and eye only.
Recessive mutations in SDCCAG8 explain 3.3 % (6/182) of cases in our worldwide SLSN
cohort. To indicate the phenotypic relation of SDCCAG8 loss of function to other NPHP-
RC we gave the related protein the aliases “SLSN7” and “NPHP10.
SDCCAG8 spans 244 kb on chromosome 1q44 (Fig. 1c). Up to 22 different putative
alternatively spliced SDCCAG8 transcripts encoding different proteins have been proposed
(www.aceview.org). To identify the relevant transcripts we designed primers
complementary to the different potential splice variants and confirmed by sequencing the
existence of 3 SDCCAG8 isoforms in retinal hTERT-RPE1 cells (Supplementary Fig. 3A).
The full-length cDNA of SDCCAG8 (isoform-a; NM_006642) encodes an 82.7-kDa protein
(713 amino acids) (Fig. 1d). Isoform-b lacks exon 6 compared to isoform-a, and isoform-e is
C-terminally truncated beyond exon 9 (Supplementary Fig. 2I). Northern blot analysis had
described a single 3.3 kb band expressed at low levels in mouse liver, spleen, kidney, brain,
heart and muscle, consistent with the full-length (isoform-a) of 3,267 nt.20 The full-length
cDNA of SDCCAG8 encodes an 82.7-kDa protein (713 amino acids) (Fig. 1e). Northern
blot data and the finding that homozygous truncating mutations are found in most exons of
full-length isoform-a (Fig. 1d-f) support the notion that this full-length isoform is the
relevant one for the retinal-renal phenotype of this disease. Analysis of the deduced
SDCCAG8 amino acid sequence yielded an N-terminal globular domain, a nuclear
localization signal, and eight putative coiled-coil domains (Fig. 1e).20 Coiled coil domains
represent a feature that is shared by most proteins mutated in NPHP-RC. Nuclear
localization signals are also found in INVS and CEP290.21 In addition to being part of the
photoreceptor sensory cilium proteome, SDCCAG8 (“serologically defined colon cancer
antigen 8”; also known as CCCAP) is part of the human centrosomal proteome.22 The
predicted SDCCAG8 protein sequence is highly conserved including Ciona intestinalis (sea
squirt) (XP_002120666.1, 20% identity), and D. melanogaster (NP_732086.1; 16% aa
identity), suggesting a conserved function of the domain assembly (Data available from the
authors). By yeast-2-hybrid interaction the SDCCAG8 protein had been shown to
homodimerize.20
SDCCAG8 colocalizes with other NPHP-RC proteins at centrosomes
Because SDCCAG8 has been described as part of the human centrosomal proteome20,23,
and since a defining feature of NPHP-RC proteins is their expression at centrosomes12,24,
we evaluated SDCCAG8 subcellular localization using immunofluorescence studies in the
renal epithelial cell line MDCK-II (Fig. 2).
For this purpose we generated antibodies against N-terminal and C-terminal peptides of
human SDCCAG8 (Fig. 1e). Antibodies α-SDCCAG8-NR, α-SDCCAG8-NG (raised
against N-terminal peptides in rabbit and guinea pig, respectively) and α-SDCCAG8-CG
(raised against C-terminal peptide in guinea pig) recognized upon immunoblotting
endogenous and stably overexpressed SDCCAG8 full-length isoform-a of human and mouse
SDCCAG8 (Supplementary Fig. 2A). α-SDCCAG8-NR also recognized isoform-a of
zebrafish (Supplementary Fig. 2B). Upon coimmunoprecipitation of human retinal epithelial
cell (hTERT-RPE) lysates with antibody α-SDCCAG8-PR (Proteintech, rabbit)
immunoblotting recognized the SDCCAG8 full-length isoform-a (83 kDa) and isoform-b
(78 kDa) when antibodies α-SDCCAG8-PR, α-SDCCAG8-NR, α-SDCCAG8-NG or α-
SDCCAG8-CG were used. In contrast to antibodies α-SDCCAG8-PR and α-SDCCAG8-
NR, α-SDCCAG8-CG did not recognize the short isoform-e at 41 kDa (Supplementary Fig.
2C-F), as the respective peptide is not part of short isoform-e (Fig. 1e). Immunofluorescence
studies confirmed that these antibodies recognize overexpressed SDCCAG8 upon indirect
immunofluorescence (Supplementary Fig. 3A-C) and that α-SDCCAG8-PR and α-
SDCCAG8-NG colocalize in connecting cilia of mouse photoreceptors (Supplementary Fig.
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3C). Taken together, these data demonstrate that these antibodies are specific for the full-
length SDCCAG8 isoform-a and antibodies -PR and -NR also recognize C-terminal short
isoform-e. We confirmed the presence of SDCCAG8 isoforms-a, -b and -e (Supplementary
Fig. 3A) by RT-PCR in hTERT-RPE cells and direct sequencing (data not shown).
When we evaluated SDCCAG8 subcellular localization by immunofluorescence studies in
the MDCK-II renal epithelial cell line, we found that SDCCAG8 localizes to centrosomes,
however in a location set apart from the γ-tubulin signal that marks centrioles (Fig. 2a), and
set apart from the signal of Cep164 that marks distal centrosomal appendages (Fig. 2b)22. In
contrast, there was tight colocalization with ninein, a marker of centrosomal appendages
(Fig. 2c)22. Colocalization was found between SDCCAG8 and NPHP5/IQCB1 (Fig. 2d) as
well as OFD1 (Fig. 2e), which are mutated in NPHP-RC. By expression of human
SDCCAG8 in mIMCD3 mouse renal epithelial cells we demonstrated expression of full-
length isoform-a at centrosomes, whereas the N-terminal short isoform-e was primarily
located in the cytoplasm (Supplementary Figure 2D). In addition, there was localization of
SDCCAG8 at cell-cell junctions (Fig. 2a-e)25 similar to what has been described for NPHP1
and NPHP4.
SDCCAG8 occurs at centrosomes throughout the cell cycle
Because proteins mutated in NPHP-RC localize to cilia and centrosomes, which become the
mitotic spindle poles bodies24, we examined subcellular SDCCAG8 localization in relation
to cell cycle in MDCK-II cells using γ-tubulin as a centrosomal marker (Supplementary Fig.
4) and α-tubulin as a cytoplasmic microtubule marker (Supplementary Fig. 5). We
demonstrate in cells stably transfected with C-terminally GFP-labelled SDCCAG8, that
SDCCAG8 localizes to the centrosomes throughout the cell cycle, as shown by its co-
localization with γ-tubulin (Supplementary Fig. 4) and α-tubulin (Supplementary Fig. 5),
respectively. Additionaly, in both hTERT-RPE1 (ciliated; Supplementary Fig. 6A-B) and
U2OS osteosarcoma cells (non ciliated; Supplementary Fig. 6C-D), SDCCAG8 localizes to
each centriole on a centrosome. Similar to what has been described for OFD1,25 SDCCAG8
is present in all cell cycle phases at the distal part of both centrioles as shown by its co-
localization with centrin, a distal centriolar marker (Supplementary Fig. 6A and C). The
finding that SDCCAG8 is present even in non-ciliated cells and occurs at both centrioles
may indicate a more general role in centrosomal function. We conclude that SDCCAG8 is
located at the distal ends of both centrioles and that it colocalizes to centrosomes throughout
the cell cycle together with other proteins that are mutated in NPHP-RC.
SDCCAG8 directly interacts with OFD1
To further characterize the protein complex in which SDCCAG8 participates, we performed
yeast two-hybrid screening of a human retinal cDNA library, using SDCCAG8 as bait. Both,
with full-length SDCCAG8 as well as with a C-terminal fragment (aa 533-713) (Fig. 3 a and
b), we identified OFD1 as a direct interaction partner of SDCCAG8. The C-terminal OFD1
region containing the last two out of six predicted coiled-coil motifs (aa 615-1012) was
found to bind to the C-terminal region of SDCCAG8 (aa 533-713) that also carried two
predicted coiled-coil motifs (Fig. 3c). The identified interaction was validated by GST pull-
down experiments (Fig. 3d) and co-immunoprecipitation (Fig. 3e).
Dominant mutations of OFD1 cause oral-facial-digital syndrome type 1, a male-lethal X-
linked dominant condition, and recessive OFD1 mutations cause the NPHP-RC Joubert
syndrome and X-linked recessive Simpson-Golabi-Behmel syndrome type 2 (SGBS2)26.
Whereas dominant mutations in OFD1 abolish its interaction and its pericentriolar
localization, recessive mutations only weaken OFD1 interaction with lebercilin (LCA5)26.
To explore the hypothesis that a loss of binding to OFD1 as result of mutations in
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SDCCAG8 underlies the disease mechanism for SLSN in patients carrying SDCCAG8
mutations, we tested whether the SDCCAG8 mutations, p.C649fsX658 or p.E474fsX493,
affect interaction with OFD1. In a liquid β-galactosidase assay, demonstrating activation of
the LacZ reporter, we identified that only the SDCCAG8 p.E474fsX493 mutation that
affects the OFD1 interacting domain completely disrupts the interaction, whereas no
difference in binding affinity for OFD1 was observed for the C-terminal p.C649fsX658
mutation (Fig. 3f). Similarly, we also assessed the effects on SDCCAG8 binding affinity of
six previously published OFD1 mutations, p.K948fs and p.E923fs26, p.I784fs27,
p.E709fs28, p.N630fs29, and p.S586fs30. All dominant OFD1 mutations disrupted the
binding, while only the p.E709fs mutation did not affect the affinity for SDCCAG8 (Fig.
3g).
SDCCAG8 colocalizes with other NPHP-RC proteins to photoreceptors
To elucidate the role of SDCCAG8 in the pathogenesis of NPHP-RC we examined
expression of SDCCAG8 and other proteins mutated in NPHP-RC for potential
colocalization in mouse retina using indirect immunofluorescence studies (Fig. 4). We detect
a strong signal for SDCCAG8 with antibody α-SDCCAG8-CG in transition zone and a
weaker signal in inner segments of mouse photoreceptors (Fig. 4a). This localization was
confirmed at high resolution-3D fluorescence imaging following electroporation of two
different human SDCCAG8 constructs into rat retina (Fig. 4b-c). Specifically, human full-
length SDCCAG8 isoform-a localizes to transition zone of photoreceptor cells (Fig. 4b),
whereas the short N-terminal isoform-e exhibits expression in connecting cilia, inner
segments, and the cytoplasm (Fig. 4c). This confirms the finding in mIMCD3 renal
epithelial cells that full-length SDCCAG8 isoform-a localizes to the vicinity of centrosomes
whereas the short N-terminal isoform-e shows diffuse cytoplasmic expression
(Supplementary Fig. 3D).
We then examined SDCCAG8 localization in mouse photoreceptors at high resolution. We
demonstrate that SDCCAG8 is located in the transition zone, distal to basal body marker γ-
tubulin in a contiguous but not overlapping position (Fig. 4d), and distal to, but clearly set
apart from the pericentriolar marker CEP290 (Fig. 4e). This subcellular localization at fine
resolution mirrors the findings of centrosomal localization in MDCK-II cell lines, where
SDCCAG8 located just distal to the centrosomal marker γ-tubulin (Fig. 2a). We tested for
colocalization with NPHP5, because NPHP5 is located in photoreceptor transition zone6 and
shares a similar genotype-phenotype correlation with SDCCAG8, in that homozygous
truncating mutations cause the retinal-renal ciliopathy Senior-Loken syndrome. As
demonstrated in MDCK-II cells (Fig. 2a-d) we detect tight colocalization of SDCCAG8 with
NPHP5 in photoreceptor transition zone (Fig. 4f), compatible with the notion of a shared
function of both proteins in photoreceptors. A similar result was obtained with antibody α-
SDCCAG8-PR (data not shown). Immunogold labeling of antibody α-SDCCAG8-PR
confirmed upon ultrathin sectioning of mouse retina that SDCCAG8 expression is
particularly prominent at the distal basal body and the transition zone of mouse
photoreceptors (Fig. 4g). Immunofluorescence studies also demonstrated colocalization of
SDCCAG8 with the retinitis pigmentosa proteins RPGRIP and RP1 (Supplementary Fig. 7).
Sdccag8 knockdown causes multiple developmental defects in zebrafish
Morpholino oligonucleotide (MO)-mediated gene knockdown in zebrafish has been
successfully employed in disease models of human NPHP-RC, yielding phenotypes of
kidney cysts, brain defects and phenotypes of body axis development.2,7 To utilize the
zebrafish model we demonstrated cross-reactivity of the antibody α-SDCCAG8-NR against
zebrafish SDCCAG8 (Supplementary Fig. 2B). We examined for sdccag8 knockdown
zebrafish phenotypes using an MO directed against the start codon (AUGMO1) as well as
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against the donor splice site of exon 6 (SPMO2), both of which efficiently abrogated
expression of SDCCAG8 protein (Fig. 5a). Compared to standard control morpholino (Fig.
5b), sdccag8 knockdown using both MOs resulted in a developmental phenotype of body
axis curvature and shortened and broadened tails (Fig. 5c-e). In addition, AUGMO
knockdown caused kidney cysts at 72 hpf in 34% (n=243) of zebrafish (Fig. 5f,h) compared
to standard MO negative control (3%, n=158) (Fig. 5g,i). Furthermore, hydrocephalus
resulted in 36% (n=128) of knockdown zebrafish (Fig. 5f,j) compared to standard MO
negative control (7%, n=158) (Fig. 5g,k). These findings demonstrate loss of sdccag8
function results in multiple developmental phenotypes that have been described in related
NPHP-RC genes including invs, cep290, and nek8 pointing to possible shared disease
mechanisms.
Loss of Sdccag8 function disturbs renal epithelial lumen formation
Formation of lumen-containing spheroids by renal epithelial cells in 3D culture is an
established test for cell polarity defects31,32, which are central to the pathogenesis of
NPHP-RC33. For the proteins NPHP1 and NPHP4 it was shown that their knockdown leads
to abnormal lumen formation in the 3D culture spheroid assay.25 To investigate the role of
SDCCAG8 in 3D kidney architecture, we transfected mIMCD3 cells with siRNA
oligonucleotides against murine Sdccag8, random sequences (negative control), or murine
Ift88, which causes a very severe NPHP-RC phenotype if mutated (positive control).34
Using quantitative RT-PCR, we determined that Sdccag8 transcript levels were depleted by
80% and Ift88 was depleted by 89% (data not shown).
We next examined whether Sdccag8 depletion would affect 3D spheroid growth in matrigel.
After 3 days of culture, cells transfected with control random oligonucleotides formed
spheroid structures with a clear lumen, apical cilia, defined tight junctions and clear
basolateral structure. Cells transfected with siIft88 developed virtually no spheroids, or grew
as clumps of cells with few cilia evident. Cells transfected with siSdccag8 developed
spheroids with architectural defects characterized by disturbed localization of β-catenin at
the basolateral membrane, fewer tight junctions, and an irregular lumen. Abnormal lumina
were clearly seen upon siSdccag8 knockdown (in 75.8% spheroids with siSdccag8
knockdown, versus 19.5% for control siRNA; p=0.0055). To exclude the possibility that the
effect observed was due to off-target effects, we stably transfected mIMCD3 cells with full-
length human SDCCAG8. We confirmed that these stable lines are still capable of forming
spheroids with only occasional irregular lumina (16.7%; data not shown). We then repeated
the siRNA of the endogenous murine Sdccag8 ortholog and observed no significant change
in lumen irregularities (16.7%) compared to negative control siRNA (19.5%). The
phenotypic rescue of Sdccag8 knock-down by co-expression of human SDCCAG8, supports
the conclusion that lack of SDCCAG8 induces a defect in cell polarity and lumen formation
which may reflect renal tubular defects present in individuals with a congenital SDCCAG8
mutation.
SDCCAG8 abandons cell-cell junctions in response to increased intracellular cAMP
Increased levels of intracellular cAMP have been strongly associated with the renal cystic
phenotype of NPHP-RC35. Pharmacologic reduction of intracellular cAMP levels by use of
the vasopressin-2-receptor antagonist tolvaptan or the somatostatin analog octreotide
reduced renal cystic disease in mouse models of NPHP-RC including the mouse model
(Pcy) of Nphp3 loss of function36. These drugs are currently tested in phase II trials in
humans with polycystic kidney disease37. We therefore studied whether localization of
SDCCAG8 at cell-cell junctions (Fig. 2a-e) would be altered upon changes of intracellular
cAMP.
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We demonstrate that upon increasing doses of the analog 8Br-cAMP there is dose-
dependent loss of SDCCAG8 from cell-cell junctions in relation to three controls, i.e.
peripheral E-cadherin, centrosomal γ-tubulin, and centrosomal SDCCAG8 (Fig. 6) (see also
Supplementary Fig. 8 Online). The same effect was seen upon treatment of serum starved
cells with forskolin and IBMX, which increase endogenous intracellular cAMP via
stimulation of adenylyl cyclase and inhibition of phosphodiesterase, respectively, and it was
reversible with the adenylyl cyclase inhibitor tolvaptan (Supplementary Fig. 9 Online). We
conclude that SDCCAG8 translocates away from cell-cell junctions in response to increased
intracellular cAMP. Treatment of spheroids with 8Br-cAMP did not result in an effect
similar to SDCCAG8 knockdown in spheroids, suggesting that redistribution of SDCCAG8
from the cell periphery in response to 8Br-cAMP and disruption of lumen formation in
spheroids may be independent phenomena (data not shown).
DISCUSSION
The discovery of single-gene causes of retinal-renal ciliopathies has generated novel insights
into the role of the cilia/centrosome/mitotic spindle complex (CCC) for disease mechanisms
of dysplasia and degeneration of kidney, retina, liver, cerebellum and many other organs.12
In addition, it revealed that multiple signaling mechanisms including Wnt signaling and
sonic hedgehog signaling are closely connected to ciliary and centrosomal function.
However, dozens of essential CCC components within this pathogenesis are still unknown.
18 Their identification has been limited by the fact that additional monogenic causes of
ciliopathies are very rare, often occurring only in single families of large international
cohorts9. This necessitates the ability of identifying ciliopathy-causing genes in single
families. The utility of the emerging techniques of exon capture and MP sequencing,
however, is limited by the high number of variants form normal reference sequence that they
generate. We here demonstrate the efficiency of an a priori approach to restricting the yield
of not disease-causing variants by combining homozygosity mapping and a candidate gene
approach with exon capture and MP sequencing. This approach has the potential of greatly
advancing disease gene identification in a multitude of single-gene disorders, thereby
allowing assembly of the related pathogenic pathways.
Particularly in the degenerative variants of NPHP-RC there is a theoretical time window for
prevention or treatment before degeneration of renal and retinal tissue develops in late
childhood. However, no treatment is currently available for any of these disorders. In the
“Pcy” mouse model of Nphp3 loss of function, reduction of the intracellular cAMP level
using a vasopressin-2-receptor antagonist resulted in successful delay or even abrogation of
renal cystic disease36. It will therefore be important to delineate the role of intracellular
cAMP for disease mechanisms of NPHP-RC. In this context, both the spheroid assay and the
cell culture assay described here provide useful models for the study of the relation between
intracellular cAMP levels and the function of genes mutated in NPHP-RC. These in vitro
models as well as the zebrafish model of sdccag8 loss of function lend themselves to high-
throughput testing of small molecules that may halt disease mechanisms of NPHP-RC.
ONLINE METHODS
Research subjects
We obtained blood samples and pedigrees following informed consent from individuals with
NPHP-RC and/or their parents. Approval for human subjects research was obtained from the
University of Michigan Institutional Review Board, McGill University Health Centre and
the other institutions involved. The diagnosis of NPHP-RC was based on published clinical
criteria.
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Linkage analysis
For genome-wide homozygosity mapping the GeneChip® Human Mapping 250k StyI Array
from Affymetrix was used. Non-parametric LOD scores were calculated using a modified
version of the program GENEHUNTER 2.138,39 through stepwise use of a sliding window
with sets of 110 SNPs and the program ALLEGRO40 in order to identify regions of
homozygosity as described7,13 using a disease allele frequency of 0.0001 and Caucasian
marker allele frequencies.
Exon capture array design
We custom designed an exon sequence capture hybridization 385K array (NimbleGen™) to
capture 13,221 exons of 828 selected ciliopathy candidate genes. Candidate genes were
derived from ciliopathy animal models, from the photoreceptor sensory cilia proteome15,
the human centrosomal proteome23, and from the cilia proteome database16
(Supplementary Table 3). DNA capture resulted in an average 200-fold enrichment of
targeted exons. Captured DNA fragment size was reduced by exo- and endonuclease
treatment to be suitable for high throughput sequencing on a Solexa/Illumina™ GA2
platform. In order to generate random start position for MP sequencing, ablate NimbleGen
linker sequences and to reduce fragment sizes, we digested the captured DNA fragments
with exonuclease Bal-31 (New England Biolabs) and endonuclease DNase I (Roche). 5 μg
DNA was digested with 2 units of Bal-31 exonuclease for 5 min at 30°C in a 200 μl
reaction. The reaction was stopped by adding EGTA to a final concentration of 20 mM and
immediate heat inactivation at 65°C for 10 min, followed by Qiaquick PCR column
purification (Qiagen). DNA (about 2 μg) was further digested by incubating with 1 unit
DNAse I (Roche) and freshly prepared reaction buffer [2× reaction buffer contains 20 mM
Tris-Cl (pH 7.5), 2 mM CaCl2, and 20 mM MnCl2] for 3 min at 16°C. The reaction was
stopped by adding 2 μl EDTA (500 mM) and immediate heat inactivation at 65°C for 10
min.
Massively parallel sequencing
Library construction (adapter ligation) of the modified captured fragments was performed
using “Genomic DNA Sample Prep Kit” according to the manufactures instructions
(Illumina, San Diego, CA) and fragments separated on a 1.5% agarose gel and excised in the
150-200 bp range. Fragments were purified and subjected to 10 rounds of PCR amplification
using complementary linker specific primers. Amount and size distribution of each sample
was analyzed on a Bioanalyzer 2100 (Agilent Technologies, Inc). Single-stranded DNA
fragments were annealed to a flow cell surface in a cluster station (Illumina) and 46 cycles
of bridge amplification were applied. Fragments were run on a single lane of a Solexa/
Illumina Genome Analyzer II platform, generating about 6-14 million single-end sequence
reads of 36-39 bases each. Image analysis and base calling was generated by the Genome
Analyzer Pipeline 1.5 with default parameters. Illumina specific FASTQ file containing
sequence information and quality scores for each base call were exported for further
analysis. Sequence evaluation was performed with the CLC™ Genomics Workbench
software. On average we obtained about 10 million single short reads (5.8-14 million) per
lane with 68% of reads on target (range 51%-81%). The median sequencing depth per
coding nucleotide was 49 with 99% of the targeted exons covered at least 5-fold.
Bioinformatics
Genetic location is according to the March 2006 Human Genome Browser data (http://
www.genome.ucsc.edu).
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cDNA cloning
To generate inducible SDCCAG8-EGFP the SDCCAG8 open reading frame was subcloned
by PCR from full length human ESTs (SDCCAG8 human EST Clone ID: 5174799) into the
vector pRetroX-Tight-Puro (Clontech). RT-PCR was performed to identify SDCCAG8
isoforms in hTERT-RPE1 cell line. For in vivo photoreceptor localization studies, the wild-
type and mutant human SDCCAG8 cDNAs were cloned into a custom-made pCAG-V5-
cDNA-IRES-EGFP-pA Gateway destination expression vector using LR clonase II
(Invitrogen) mediated recombination.
Yeast two-hybrid assays
The GAL4-based yeast two-hybrid system (HybriZAP, Stratagene, La Jolla, USA) was used
for identifying protein-interaction partners of SDCCAG8. The SDCCAG8 full-length and
fragments (amino acids 1-294, 286-541, 533-713) fused to a DNA-binding domain (GAL4-
BD), were used as baits for screening a human oligo-dT primed retinal cDNA library. The
yeast strain PJ69-4A, which carried the HIS3 (histidine), ADE2 (adenine), MEL1 (alpha-
galactosidase) and LacZ (beta-galactosidase) reporter genes, was used as a host. Interactions
were analyzed by assessment of reporter gene activation via growth on selective media
(HIS3 and ADE2 reporter genes), alpha-galactosidase colorimetric plate assays (MEL1
reporter gene), and beta-galactosidase colorimetric filter lift assays (LacZ reporter gene). For
analysis of the binding capacities of SDCCAG8 mutant proteins to OFD1, expression
constructs encoding SDCCAG8 as a GAL4-BD fusion protein, either wild-type or
containing the p.C649fsX658 or p.E474fsX493 mutation were cotransformed in PJ694a with
a construct pAD-OFD1 isoform-3, encoding OFD1 as a GAL4-AD fusion protein. For
analysis of the binding capacities of OFD1 mutant proteins to SDCCCAG8, expression
constructs encoding amino acids 356–1012 of OFD1 as a GAL4-AD-fusion protein, either
wild-type or containing the p.K948fs, p.K923fs, p.I784fs, p.E709fs, p.N630fs, or p.S586fs
mutation, were cotransformed with a construct encoding the full-length SDCCAG8 fused to
GAL4-BD (pBD-SDCCAG8) in PJ69-4a. As a negative control, the empty pAD vector was
cotransformed with pBD-SDCCAG8. Detailed protocols for evaluation of the protein
interactions are available from the authors.
GST Pull-Down Assay
SDCCAG8 full-length and fragments (amino acids 1-294, 286-541, and 533-713) were
cloned into pDEST15 (Gateway cloning system, Invitrogen). For the creation of GST-fusion
proteins, BL21-DE3 cells were transformed with pDEST15 constructs. Detailed protocols
for GST pull down are available from the authors.
Coimmunoprecipitation
HA-SDCCAG8 (full-length) and 3xFLAG-OFD1 (both splice variants and the fragments
encompassing amino acids 356–1012) were coexpressed in HEK293T cells. As a negative
control, HA-SDCCAG8 was coexpressed with the functionally unrelated 3xFLAG-dN-p63
protein. After 48 hr of expression, cells were lysed on ice in lysis buffer (50 mM Tris–HCl
[pH 7.5], 150 mM NaCl, 0.5% Triton X-100) supplemented with complete protease inhibitor
cocktail. Lysates were incubated with anti- FLAG M2-agarose from mouse (Sigma-
Aldrich), for 5 hr at 4 degrees Celsius. After incubation, beads with bound protein
complexes were washed in lysis buffer. Then beads were taken up in NuPage Sample Buffer
and heated for 10 min at 70 degrees Celsius. Beads were precipitated by centrifugation, and
supernatant was run on a NuPAGE Novex 4%–12% Bis-Tris SDS-PAGE gel. The
interaction of HA-SDCCAG8 with 3xFLAG-OFD1 was assessed by immunoblotting,
followed by staining with either monoclonal mouse anti-FLAG or monoclonal mouse anti-
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HA (Sigma-Aldrich) as a primary antibody and goat anti-mouse RDye800 as a secondary
antibody. Fluorescence was analyzed on a Li-Cor Odyssey 2.1 infrared scanner.
Antibodies
Antipeptide antibodies were raised against the following targets: α-SDCCAG8-NG (raised
against human N-terminal peptide PN (Fig. 1e) in guinea pig, aa 119-138), α-SDCCAG8-
CG (raised against C-terminal peptide PC (Fig. 1e) in guinea pig, aa 483-502) and α-
SDCCAG8-NR (raised against N-terminal peptide PN (Fig. 1e) in rabbit, aa 119-138).
Cystein was added to the N-terminus of peptides to facilitate the coupling to maleimide
activated mcKLH (Thermo Fisher Scientific, Rockford, IL). Rabbits or Guinea Pigs were
then immunized with KLH-coupled peptides (Cocalico Biologicals Inc, Reamstown, PA).
To affinity purify peptide antibodies, appropriate peptides were coupled to Sulfolink resin
according to manufacturers recommendation (Thermo Fisher Scientific).The following
primary antibodies were used: mouse anti-GFP (Clontech); mouse anti-γ-tubulin (Sigma),
mouse anti-acetylated-α-tubulin (Sigma), rabbit anti-γ-tubulin (Sigma), mouse anti-β actin
(BD Biosciences), mouse-anti-glutamylated tubulin (Sigma), mouse anti-Centrin (M. Dias),
mouse anti-GT335 (C. Janke); rabbit anti-ninein (Biolegend); rabbit anti-SDCCAG8
(Proteintech), rabbit anti-Nphp5 (E. Otto), rabbit anti-OFD1 (E. Nigg), anti-OFD1-GR
(GenTex), rabbit anti-Cep164 (E. Nigg), rabbit ant-CEP290 (B. Chang), rabbit anti-γ-
catenin (BD Biosciences), rabbit anti-ZO1 (P. Jackson), rabbit anti-Ecadherin (BD
Biosciences), anti-FLAG (Sigma), anti-HA (Sigma). Alexa-488, Alexa-594 and Alexa-647
conjugated secondary antibodies were obtained from Invitrogen.
mIMCD3 spheroid growth assay
Mouse kidney collecting duct mIMCD3 cells were cultured in DMEM:F12 1:1 in 10% FBS.
25,000 cells were seeded per well in 24-well dishes (plastic and glass bottom) in triplicate
24 hours prior to being transfected with 50 nM Dharmacon OTP siRNA against mouse
Sdccag8 (smartpool, L-045871-01-0005), mouse Ift88 (J-050417-06), or control (Ctrl;
D001206-14-05, SiGenome) random oligos. One plate was harvested to determine knock-
down efficiency by quantitative real-time PCR three days later, another was fixed in 4%
PFA and immunostained for acetylated tubulin (T7451, Sigma, 1:2,000) and pericentrin
(PRB-432C, Covance, 1:500), and scored for % nuclei with cilia (n=300-700 nuclei
counted). The third plate was used to examine the effect of Sdccag8 on spheroid growth in
3D culture conditions. The detailed protocol is available from the authors.
For quantitative real-time PCR, total RNA was prepared using the RNeasy Mini kit
(QIAGEN). 100 ng of the total RNA was added to a master mix with One-step RT-PCR
reagents (Applied Biosystems 4309169) and Taqman Gene Expression Assays (Applied
Biosystems) for each individual gene: Sdccag8 (Mm00659616_m1), Ift88
(Mm00493675_m1), Rpl19 (Mm02601633_g1). Triplicate reactions were run and analyzed
on an ABI 7500 thermocycler. The mRNA levels of Ift88 and Sdccag8 were normalized to
the endogenous Rpl19.
Immunofluorescence and confocal microscopy in cell lines and mouse retina
For immuno-staining MDCK-II cells, cells were seeded onto 0.4 μm Transwell filters
(Corning, Lowell, MA) and grown for 7 days post-confluency. For immuno-staining
centrosomes and basal body, filters were incubated in ice cold acetone:methanol (1:1) for 10
minutes. Filters were then rehydrated in PBS prior to blocking in 2% goat serum/PBS. For
all other immuno-staining, filters were fixed for 20 minutes in 4%PFA/PBS followed by a
10 minutes permeabilization step in 0.1%Triton-X100/PBS. Filters were then blocked as
above. Primary antibody incubations were performed overnight in 2% goat serum/PBS.
Secondary antibody and DAPI incubations were performed for 1 hour. Filters were mounted
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in Prolong Gold antifade reagent (Invitrogen). For immunostaining hTERT-RPE cells, cells
were grown on #1 coverslips and fixed and stained as above. Confocal imaging was
performed using Leica SP5X system with an upright DM6000 compound microscope and
images were processed with the Leica AF software suite. Immunofluorescence of mouse
retina was performed essentially as described41. The dilutions of various antibodies used are
as follows: SDCCAG8-PR (Proteintech, 1:1000), SDCCAG8-CG (guinea pig 1:800), Ninein
(1:500), NPHP5 (1:1000), OFD1 (Nigg, 1:200), Cep164 (1:1000), Cep170 (1:500), CEP290
(Chang et al., 2006, 1:500), RPGRIP1L (Khanna et al., 2009; 1:1000), VHL, SCBT
(1:1000), Acetylated α-tubulin (Sigma 1:1000).
Electronmicroscopy studies
For immunogold labeling studies of mouse retina mouse eyecups were fixed in 0.25%
glutaraldehyde + 4% formaldehyde in 0.1 M cacodylate buffer, pH 7.4, and processed for
embedment in LR White. Ultrathin sections (70 nm) were labeled with primary antibody,
followed by secondary antibody conjugated to 12 nm gold.
In vivo electroporation of rat retinas
We used the in vivo electroporation technique to express human SDCCAG8 proteins in rat
photoreceptor cells. Injected plasmids were electroporated into retinal cells using tweezer-
type electrodes in the right eyes of neonatal rats (n=6-8 rats/injection) as described.42
Animals were sacrificed 4 weeks following transfection, and 60 μm thick sections of the
transfected portions of retinas were then prepared from the portions of the eyecups with
EGFP signal. Sections were stained with anti-V5 antibodies (Invitrogen), followed by
Alexa-555 conjugated secondary antibodies (Invitrogen), and imaging using a Zeiss
LSM510 confocal microscope. Three-dimensional reconstructions of the confocal image
stacks were generated and analyzed using Volocity 3D imaging software (Improvision,
Waltham, MA).
Zebrafish morpholino oligo-mediated knockdown
Morpholino oligonucleotides (MOs) were obtained from Gene Tools, LLC (Philomath, OR).
The sequences of the morpholino oligonucleotides used are given in Supplementary Table 1
Online. Fertilized eggs were microinjected with the specified amount of MO dissolved in
0.1M KCl. JB4-embedded sections were prepared as described previously. 6 μm sections
were stained with methylene-blue and imaged with a compound microscope. To examine the
zebrafish sdccag8 protein, 24 hpf embryos were lysed with RIPA buffer containing protease
inhibitor.
Statistical analysis
Student’s two-tailed nonpaired t-tests and normal distribution two-tailed z-tests were carried
out using pooled standard error and s.d. values to determine the statistical significance of
differences between samples. The significance level was set at P < 0.05.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Homozygosity mapping, exon capture, and massively parallel sequencing identifies
SDCCAG8 mutations as causing nephronophthisis with retinal degeneration
(a) Non-parametric LOD (NPL) scores across the human genome in 2 sibs with
nephronophthisis and retinal degeneration of consanguineous family SS23/A1365. X-axis
gives Affymetrix 250k StyI array SNP positions on human chromosomes concatenated from
p-ter (left) to q-ter (right). Genetic distance is given in cM. Four maximum NPL peaks (red
circles) indicate candidate regions of homozygosity by descent.
(b) Exon capture of 828 ciliopathy candidate genes with consecutive massively parallel
sequencing and sequence evaluation within the 4 mapped homozygous candidate regions
(red circles in “a”) yields mutation of SDCCAG8 in SS23/A1365.
(c) The SDCCAG8 gene extends over 244 kb and contains 18 exons (vertical hatches).
(d) Exon structure of human SDCCAG8 cDNA. Positions of start codon (ATG) and of stop
codon (TGA) are indicated. For mutations detected (see f ) arrows indicate positions relative
to exons and protein domains (see e).
(e) Domain structure of the SDCCAG8 protein. N-terminal globular domain (NGD), nuclear
localization (NLS) domain, coiled-coil domains (CC), and glutamine-rich region (Gln_rich).
PN and PC denote peptides used for antibody generation.
(f) Eight homozygous SDCCAG8 mutations detected in 8 families with nephronophthisis
and retinal degeneration. Family number, mutation and predicted translational changes are
indicated (see Table 1). A homozygous deletion covering exons 5-7 is demonstrated by
agarose gel electrophoresis. Sequence traces are shown for mutations above normal controls.
Mutated nucleotides are indicated by arrow heads in traces of normal controls.
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Figure 2. Indirect immunofluorescence detects SDCCAG8 at centrosomes together with other
proteins mutated in NPHP-RC
(a) Centrosomal SDCCAG8 is at centrosomes but slightly set apart from the signal of γ-
tubulin, which marks the centrioles and from CEP164 (b), which marks distal centrosomal
appendages22. (c) In contrast, there is tight colocalization with ninein, a marker of
centrosomal appendages22. There is also colocalization at centrosomes with NPHP5 (d) and
OFD1 (e) previously found to be mutated in NPHP-RC6,26. Size bars represent 5 μm. Insets
show enlargement of representative results at 5-fold higher magnification. Nuclei are stained
with DAPI. Antibody α-SDCCAG8-CG was used to detect SDCCAG8.
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Figure 3. SDCCAG8 Interaction with OFD1
(a, b) Schematic of SDCCAG8 and OFD1 clones and protein domains. Full-length
SDCCAG8 (Q86SQ7) and three cloned fragments are shown (a) as well as OFD1 fragments
identified by yeast two-hybrid screening and isoforms O75665-1 and O75665-3.
(c) Yeast two-hybrid interaction assays confirmed binding of full-length SDCCAG8 and C-
terminal fragment (533-713) to all cloned OFD1 fragments, except isoform-3. HIS3 and
ADE2 reporter genes activation is indicated.
(d) Both GST-SDCCAG8 full-length and the GST-SDCCAG8 C-terminal fragment
efficiently pulled down 3xFLAG-tagged OFD1 isoform-3, contrary to GST alone.
(e) 3xHA-tagged full-length SDDCAG8 coimmunoprecipitated with 3xFLAG-tagged OFD1
isoform 3, and fragment 356-1012, contrary to unrelated 3xFLAG-tagged ΔN-p63. Panel 2
shows 5% of cell lysate input.
(f) Interaction of wild-type (WT) and SDCCAG8 mutants with ODF1 isoform-1 in beta-
galactosidase assay. Constructs encoding SDCCAG8 as GAL4-BD fusion protein, WT or
indicated mutants, were cotransformed with pAD-OFD1 isoform-3 constructs in yeast.
Cotransformation of pBD-SDCCAG8 and pAD-MUT vector served as negative control.
Remaining LacZ reporter gene activity, corrected for background activity, is indicated.
(g) Interaction of WT isoform-3 and OFD1 mutants with SDCCAG8 in yeast two-hybrid
assay. Constructs encoding WT SDCCAG8 as GAL4-BD fusion protein were cotransformed
in PJ694a with pAD-OFD1 isoform-3 constructs, WT or indicated mutations. Interaction of
SDCCAG8 with OFD1 mutant p.E709fs and WT was detected as described above. Beta-
galactosidase assays revealed decreased LacZ reporter gene activity for OFD1 all mutations
except E709fs, indicating significantly reduced interaction with SDCCAG8. Error bars
represent standard error of the mean in f and g.
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Figure 4. SDCCAG8 is located in mouse photoreceptor basal bodies and connecting cilia
transition zone
(a) Immunofluorescence using the α-SDCCAG8-CG antibody demonstrates strong
SDCCAG8 expression in transition zone of connecting cilia (cc) and weak expression in
inner segments (IS) of mouse photoreceptors.
(b-c) Upon in vivo electroporation into rat retinae, human full-length SDCCAG8 isoform-a
(red) (b) localizes to transition zone of photoreceptor cells (level of arrow), whereas the
short N-terminal isoform-e (red) (c) exhibits expression in transition zone (level of arrow),
inner segments (level of bracket) and cytoplasm (level of arrow head). Photoreceptor
cytoplasms are counterstained by GFP overexpression (green).
(d) In mouse photoreceptors SDCCAG8 is located in transition zone of connecting cilia,
distal to basal body marker γ-tubulin in a contiguous but non-overlapping location.
(e) SDCCAG8 is located in the transition zone, distal to, and clearly set apart from the
pericentriolar marker CEP290.
(f) SDCCAG8 tightly colocalizes with NPHP5. Scale bars are 10 μm. Insets in d-f show
enlargement of representative results at 3-fold higher magnification.
(g) Upon ultrathin sectioning of mouse retina SDCCAG8 expression is particularly
prominent at distal basal body (bracket) and the transition zone (winged bracket) connecting
cilium of mouse photoreceptors (antibody α-SDCCAG8-PR). The bar graph represents the
density of immunogold labeling over the photoreceptor transition zone (TZ), basal bodies
(BB) and inner segments (IS) after subtracting background labeling. Scale bar = 100 nm.
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Figure 5. sdccag8 knockdown results in multiple developmental defects
(a) Injection of both sdccag8-targeting MOs abrogates sdccag8 protein from MO injected
embryo morphant lysates. sdccag8 protein is detected by the α-SDCCAG8-NR antibody as a
single band in uninjected embryos, compatible with the sdccag8 full-length product at ~83
kDa (arrow head). Anti-α-tubulin antibody was used to demonstrate equal loading.
(b-d) In comparison to embryos injected at the 2-cell stage with standard negative control
MO (b) embryos injected with AUG-targeting MO (c) or splice site targeting MO (d,e)
exhibit a dose-dependent phenotype of body axis curvature and shortened and broadened
tails at 24 hpf.
(f-k) Knockdown of sdccag8 in zebrafish embryos at 72 hpf caused pronephric cysts as
evidenced by a rounded structure (arrow in f) and hollow spaces (asterisk in h) compared to
control morpholino injected control (g,j) , which shows slender pronephric tubular lumina
(arrows in i). It also caused hydrocephalus (asterisk in j) compared to control morpholino
injected control (g,k). Scale bars represent 1 mm in b-g and 100 μm in h-k.
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Figure 6. siRNA knockdown of siSdccag8 perturbs lumen formation of renal epithelial cells in
3D spheroid culture
(a) IMCD3 murine renal epithelial cells, when grown in 3D matrigel culture for 3 days,
polarize as demonstrated by staining for β-catenin (green) and tight junction marker ZO1
(red). They ciliate apically as shown by acetylated α-tubulin (white) and form a spheroid
containing a central lumen (asterisk). Nuclei are stained blue with DAPI.
(b) Upon siSdccag8 knockdown cells develop spheroids that have architectural defects
characterized by disturbed localization of β-catenin (green) away from the basolateral
membrane, fewer tight junctions (red), and an irregular lumen (asterisk). Abnormal lumina
were seen in 19.5% of siRNA controls versus 75.8% in siSdccag8 knockdown (p=0.0055).
(c) When siSdccag8 knockdown was performed in mIMCD3 cells that were stably
transfected with human full-length SDCCAG8, the knockdown phenotype was fully rescued
leading to no significant reduction in irregular lumina (16.7%) compared to negative control
siRNA (19.5%).
(d-g) SDCCAG8 abandons cell-cell junctions in response to increased intracellular cAMP.
(d) In the renal epithelial cell line MCDK-II SDCCAG8 stained with antibody α-
SDCCAG8-CG (green) is located at centrosomes and cell-cell junctions, which are marked
with an α-E-cadherin antibody (red). (e) Upon treatment with 8-Br-cAMP [100 μM], there
is dose-dependent loss of SDCCAG8 signal from cell-cell junctions relative to E-cadherin
(f-g). When 100 linear segments of the pentagonal cell-cell junctions of non-neighboring
cells were evaluated for the ratio of relative fluorescence signals for SDCCAG8 versus E-
cadherin there was a redistribution depending on cAMP concentration [μM] away from cell
junction staining for SDCCAG8 relative to peripheral E-cadherin, centrosomal γ-tubulin (f)
and relative to centrosomal SDCCAG8 (g) (see also Supplementary Figure 6 ). Error bars
represent standard error of the mean.
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